• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    RadNet and OB/GYN Specialists of the Palm Beaches Enhance Breast Cancer Screening with State-of-the-Art Imaging Services

    2/26/25 6:00:00 AM ET
    $RDNT
    Medical Specialities
    Health Care
    Get the next $RDNT alert in real time by email

    PALM BEACH, Fla., Feb. 26, 2025 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ:RDNT), a national leader in providing high-quality, cost-effective outpatient diagnostic imaging services, today announced that OB/GYN Specialists of the Palm Beaches ("OB/GYN Specialists") is launching breast imaging services across multiple locations in Palm Beach County, utilizing technologies from RadNet and its wholly-owned subsidiary, DeepHealth.

    OB/GYN Specialists is the largest provider of obstetric and gynecological care in Palm Beach County, serving nearly 60,000 women annually across 10 locations from Boca Raton to Port Saint Lucie. The strategic partnership with RadNet enables on-site mammography and breast cancer screening, using RadNet's DeepHealth diagnostic and operational artificial intelligence (AI) solutions, along with expert radiologist interpretation. This screening program aims to facilitate early detection and improve patient outcomes.

    As part of the collaboration, RadNet's contracted board-certified breast imaging radiologists will provide interpretation of all mammography and diagnostic screening exams conducted across four OB/GYN Specialists locations. This service for patients includes the Enhanced Breast Cancer Detection (EBCD) protocol, which assists with the identification of even subtle lesions sooner than otherwise would be detected without the use of AI. EBCD employs DeepHealth artificial intelligence and a comprehensive clinical review process to improve cancer detection rates. Recent studies show a 21% increase in breast cancer detection with EBCD, highlighting its importance in advancing women's health.

    In addition to RadNet's imaging services, OB/GYN Specialists will incorporate DeepHealth's AI-driven health informatics, which features a cloud-based operating system, patient tracking services, and risk assessment, designed to integrate with their electronic health records (EHR) system.

    "Our mission is to deliver comprehensive, patient-centered care for women at every stage of life," stated John Burgio, M.D., managing member of OB/GYN Specialists. "By integrating AI-powered breast health screening into our practice, we improve early detection and continuity of care. Our patients can now receive reliable, high-quality breast imaging from RadNet's specialized radiologists—all within a familiar environment."

    "All women deserve access to high-quality breast screening," said Howard Berger, M.D., president and founder of RadNet. "By bringing RadNet's technology-enabled services and imaging expertise directly into OB/GYN's offices and other point-of-care provider offices, we are making early detection more convenient, accurate, and accessible."

    This collaboration highlights RadNet and OB/GYN Specialists' shared commitment to expanding breast health services, empowering women with proactive screening options, and driving innovation in women's healthcare.

    For media inquiries or further information, please contact:

    RadNet

    Tim Merchant

    National Director of Screening Networks and Population Health Strategy

    224-250-0863

    About OB/GYN Specialists of the Palm Beaches

    OB/GYN Specialists of the Palm Beaches, since 1968, offers a comprehensive range of obstetrical and gynecological services, including routine check-ups, prenatal care, advanced treatments, and surgical interventions. We focus on evidence-based medicine and personalized care for our patients. OB/GYN fosters a supportive and welcoming environment where patients can openly discuss their health concerns and access the information necessary to make informed healthcare choices.

    For more information, visit http://www.obgynspb.com

    About RadNet, Inc.

    RadNet, Inc., is the leading national provider of free-standing, fixed-site diagnostic imaging services and related information technology solutions (including artificial intelligence) in the United States based on the number of locations and annual imaging revenue. RadNet has a network of 399 owned and/or operated outpatient imaging centers. RadNet's markets include Arizona, California, Delaware, Florida, Maryland, New Jersey, New York, and Texas. Together with affiliated radiologists, including full-time and per diem employees and technicians, RadNet has over 10,000 employees.

    For more information, visit http://www.radnet.com.



    Primary Logo

    Get the next $RDNT alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $RDNT

    DatePrice TargetRatingAnalyst
    3/5/2025$85.00 → $65.00Outperform → Strong Buy
    Raymond James
    9/6/2024$57.00 → $79.00Equal Weight → Overweight
    Barclays
    3/6/2024$48.00Equal Weight
    Barclays
    8/31/2023$40.00Buy
    Truist
    3/31/2023$30.00Market Outperform
    CJS Securities
    3/3/2023$30.00Mkt Perform → Outperform
    Raymond James
    8/12/2021Outperform → Market Perform
    Raymond James
    8/12/2021$39.00Overweight
    Barclays
    More analyst ratings

    $RDNT
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • RadNet Reports First Quarter Financial Results and Revises Upwards 2025 Financial Guidance Ranges for Revenue and Adjusted EBITDA¹

      First quarter Revenue was negatively impacted by approximately $22 million and Adjusted EBITDA(1) was negatively impacted by approximately $15 million as a result of the Southern California wildfires and severe winter weather conditionsTotal Company Revenue increased 9.2% to $471.4 million in the first quarter of 2025 from $431.7 million in the first quarter of 2024Revenue from the Digital Health reportable segment increased 31.1% to $19.2 million in the first quarter of 2025 from $14.7 million in the first quarter of 2024Aggregate procedural volumes increased 3.6% and same-center procedural volumes decreased 0.3% compared with the first quarter of 2024Total Company Adjusted EBITDA(1) was $4

      5/11/25 4:00:00 PM ET
      $RDNT
      Medical Specialities
      Health Care
    • RadNet, Inc. to Present at the Bank of America Securities 2025 Healthcare Conference on May 13th, 2025

      LOS ANGELES, May 09, 2025 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ:RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers, today announced that Mark Stolper, Executive Vice President and Chief Financial Officer will be presenting at the Bank of America Securities 2025 Healthcare Conference in Las Vegas, NV on Tuesday, May 13, 2025 at 5:00 p.m. Pacific Time. There will be simultaneous and archived webcasts available at https://bofa.veracast.com/webcasts/bofa/healthcare2025/id0NMyx8.cfm Details for RadNet's Presentation: Date:Tuesday, May 13, 2025Time:5:00 p.m. Pacific TimeLocat

      5/9/25 6:00:00 AM ET
      $RDNT
      Medical Specialities
      Health Care
    • Clinical AI Platforms Expand Globally Amid Regulatory and Market Tailwinds

      Equity Insider News Commentary Issued on behalf of Avant Technologies Inc. VANCOUVER, BC, April 29, 2025 /PRNewswire/ -- Across the western healthcare landscape, artificial intelligence (AI) is being increasingly adopted to simplify authorizations and cut through layers of bureaucratic inefficiency. Rather than replacing physicians — a scenario some tech leaders like Bill Gates have speculated about — the goal is to enhance the capabilities of healthcare professionals. Momentum in this space is being driven by recent initiatives from companies like Avant Technologies, Inc. (OTCQB:AVAI), Koninklijke Philips N.V. (NYSE:PHG), HEALWELL AI Inc. (TSX:AIDX) (OTCQX:HWAIF), RadNet, Inc. (NASDAQ:RDNT)

      4/29/25 11:10:00 AM ET
      $ICAD
      $PHG
      $RDNT
      Medical/Dental Instruments
      Health Care
      Medical Electronics
      Medical Specialities

    $RDNT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Pres & COO-Eastern Operations Forthuber Stephen M converted options into 2,760 shares and sold $1,135,599 worth of shares (18,820 units at $60.34), decreasing direct ownership by 3% to 535,182 units (SEC Form 4)

      4 - RadNet, Inc. (0000790526) (Issuer)

      5/20/25 4:15:10 PM ET
      $RDNT
      Medical Specialities
      Health Care
    • Director Levitt Lawrence L sold $305,450 worth of shares (5,000 units at $61.09), decreasing direct ownership by 3% to 164,957 units (SEC Form 4)

      4 - RadNet, Inc. (0000790526) (Issuer)

      5/20/25 4:15:08 PM ET
      $RDNT
      Medical Specialities
      Health Care
    • Pres and COO-West Operations Hames Norman R converted options into 2,760 shares and sold $506,820 worth of shares (8,447 units at $60.00), decreasing direct ownership by 1% to 249,183 units (SEC Form 4)

      4 - RadNet, Inc. (0000790526) (Issuer)

      5/15/25 8:43:59 PM ET
      $RDNT
      Medical Specialities
      Health Care

    $RDNT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by RadNet Inc.

      SC 13G/A - RadNet, Inc. (0000790526) (Subject)

      11/12/24 4:51:53 PM ET
      $RDNT
      Medical Specialities
      Health Care
    • Amendment: SEC Form SC 13G/A filed by RadNet Inc.

      SC 13G/A - RadNet, Inc. (0000790526) (Subject)

      11/4/24 1:22:38 PM ET
      $RDNT
      Medical Specialities
      Health Care
    • Amendment: SEC Form SC 13G/A filed by RadNet Inc.

      SC 13G/A - RadNet, Inc. (0000790526) (Subject)

      10/24/24 6:36:21 PM ET
      $RDNT
      Medical Specialities
      Health Care

    $RDNT
    SEC Filings

    See more

    $RDNT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Amendment: SEC Form S-4/A filed by RadNet Inc.

      S-4/A - RadNet, Inc. (0000790526) (Filer)

      5/19/25 5:23:08 PM ET
      $RDNT
      Medical Specialities
      Health Care
    • SEC Form 425 filed by RadNet Inc.

      425 - RadNet, Inc. (0000790526) (Filed by)

      5/13/25 5:15:01 PM ET
      $RDNT
      Medical Specialities
      Health Care
    • SEC Form 10-Q filed by RadNet Inc.

      10-Q - RadNet, Inc. (0000790526) (Filer)

      5/12/25 4:09:52 PM ET
      $RDNT
      Medical Specialities
      Health Care
    • RadNet upgraded by Raymond James with a new price target

      Raymond James upgraded RadNet from Outperform to Strong Buy and set a new price target of $65.00 from $85.00 previously

      3/5/25 7:50:00 AM ET
      $RDNT
      Medical Specialities
      Health Care
    • RadNet upgraded by Barclays with a new price target

      Barclays upgraded RadNet from Equal Weight to Overweight and set a new price target of $79.00 from $57.00 previously

      9/6/24 7:50:42 AM ET
      $RDNT
      Medical Specialities
      Health Care
    • Barclays initiated coverage on RadNet with a new price target

      Barclays initiated coverage of RadNet with a rating of Equal Weight and set a new price target of $48.00

      3/6/24 8:01:30 AM ET
      $RDNT
      Medical Specialities
      Health Care

    $RDNT
    Leadership Updates

    Live Leadership Updates

    See more
    • RadNet, Inc. Announces the Appointment of Kees Wesdorp as President and Chief Executive Officer of RadNet's Digital Health Division

      Former Chief Business Leader of Philips' multi-billion-dollar Precision Diagnosis division and member of Philips' Executive CommitteeEnd-to-end responsibility for Philip's CT, MR, dXR, Ultrasound and Diagnostic Informatics (radiology software) businessesProven track record of building and managing radiology software solutions, including significant experience with AI development and commercialization LOS ANGELES, Sept. 12, 2024 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ:RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers and digital health solutions, announced today the appo

      9/12/24 6:00:00 AM ET
      $RDNT
      Medical Specialities
      Health Care

    $RDNT
    Financials

    Live finance-specific insights

    See more
    • RadNet Reports First Quarter Financial Results and Revises Upwards 2025 Financial Guidance Ranges for Revenue and Adjusted EBITDA¹

      First quarter Revenue was negatively impacted by approximately $22 million and Adjusted EBITDA(1) was negatively impacted by approximately $15 million as a result of the Southern California wildfires and severe winter weather conditionsTotal Company Revenue increased 9.2% to $471.4 million in the first quarter of 2025 from $431.7 million in the first quarter of 2024Revenue from the Digital Health reportable segment increased 31.1% to $19.2 million in the first quarter of 2025 from $14.7 million in the first quarter of 2024Aggregate procedural volumes increased 3.6% and same-center procedural volumes decreased 0.3% compared with the first quarter of 2024Total Company Adjusted EBITDA(1) was $4

      5/11/25 4:00:00 PM ET
      $RDNT
      Medical Specialities
      Health Care
    • RadNet, Inc. Announces Date of its First Quarter 2025 Financial Results Conference Call

      LOS ANGELES, April 24, 2025 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ:RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and operated outpatient imaging centers, announced today that it will host a conference call to discuss its first quarter 2025 financial results on Monday, May 12, 2025 at 7:30 a.m. Pacific Time (10:30 a.m. Eastern Time). Investors are invited to listen to RadNet's conference call by dialing 844-826-3035. International callers can dial 412-317-5195. There will also be simultaneous and archived webcasts available at https://viavid.webcasts.com/starthere.jsp?ei=1717619&tp_key=f0980d090d. An archived r

      4/24/25 6:00:00 AM ET
      $RDNT
      Medical Specialities
      Health Care
    • RadNet, Inc. to Acquire iCAD, Inc. to Accelerate AI-Powered Early Detection and Diagnosis of Breast Cancer

      The acquisition will unite complementary leading AI-powered cancer detection and workflow solutions focused on improving the accuracy and early detection of breast cancerThe transaction is expected to add to RadNet's wholly owned subsidiary, DeepHealth, an installed base of over 1,500 healthcare provider locations across over 50 countriesWith iCAD's seasoned commercial and engineering team anticipated to join DeepHealth, the combination is expected to accelerate RadNet's growth and leadership in cancer screening and artificial intelligenceFollowing the completion of the acquisition, iCAD will be integrated into RadNet's DeepHealth portfolio of solutionsRadNet will host a conference call and

      4/15/25 4:01:37 PM ET
      $ICAD
      $RDNT
      Medical/Dental Instruments
      Health Care
      Medical Specialities